Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Galectin-3 concentration in bronchial tissue and BAL correlates with asthma severity

Sep. 19, 2018

Galapagos, AbbVie Sarl present mutant CFTR modulators

Sep. 18, 2018

Biogen presents phase II data for BG-00011 in IPF patients

Sep. 18, 2018

Phase II data presented for CFTR potentiator QBW-251

Sep. 17, 2018

First phase I data presented for inhaled pirfenidone

Sep. 17, 2018

Galapagos and AbbVie Sarl present CFTR mutant correctors

Sep. 13, 2018

FDA issues complete response letter for mepolizumab in COPD

Sep. 10, 2018

Carbon dioxide aggravates COPD

Sep. 10, 2018

Torrent Pharmaceuticals patents compounds for asthma and COPD

Sep. 7, 2018

OncoArendi Therapeutics presents new AMCase and CHIT1 dual inhibitors for lung diseases

Sep. 6, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 27, 2026.
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...